secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0001193125-25-169309
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica receives Nasdaq delisting notice, implements 1-for-10 reverse split to regain bid price compliance
--------------------------------------------------------------------------------

- Nasdaq Staff Determination issued July 24, 2025; company may request hearing to stay delisting.
- 1-for-10 reverse stock split effected July 24, 2025 to increase per-share bid price.
- Closing bid price $6.24 on July 29, 2025, above $1.00 minimum for 4 consecutive business days.
- Company will request bid price compliance determination after 10 trading days of compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525169309/0001193125-25-169309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525169309/d62269d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-169309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer